{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:07:40Z","timestamp":1783116460249,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,24]]},"DOI":"10.7759\/cureus.54840","type":"journal-article","created":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T03:47:31Z","timestamp":1708832851000},"source":"Crossref","is-referenced-by-count":2,"title":["Association of Inflammatory Markers With Disease Progression and the Severity of COVID-19"],"prefix":"10.7759","author":[{"given":"Stuti V","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya M","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhay J","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan J","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyal B","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arushi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten C","year":"2003","unstructured":"Drosten C, G\u00fcnther S, Preiser W, et al.. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003, 348:1967-76. 10.1056\/NEJMoa030747","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01244-13","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","volume":"87","author":"de Groot RJ","year":"2013","unstructured":"de Groot RJ, Baker SC, Baric RS, et al.. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol. 2013, 87:7790-2. 10.1128\/JVI.01244-13","journal-title":"J Virol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu N","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020, 382:727-33. 10.1056\/NEJMoa2001017","journal-title":"N Engl J Med"},{"key":"ref5","unstructured":"Coronavirus disease (COVID-19) pandemic. (2020). https.\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed asymptomatic carrier transmission of COVID-19","volume":"323","author":"Bai Y","year":"2020","unstructured":"Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020, 323:1406-7. 10.1001\/jama.2020.2565","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.05.001","article-title":"A systematic review of asymptomatic infections with COVID-19","volume":"54","author":"Gao Z","year":"2021","unstructured":"Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, Ma K. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2021, 54:12-6. 10.1016\/j.jmii.2020.05.001","journal-title":"J Microbiol Immunol Infect"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao X","year":"2020","unstructured":"Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020, 20:269-70. 10.1038\/s41577-020-0308-3","journal-title":"Nat Rev Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan L","year":"2020","unstructured":"Tan L, Wang Q, Zhang D, et al.. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020, 5:33. 10.1038\/s41392-020-0148-4","journal-title":"Signal Transduct Target Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu Z","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, et al.. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020, 8:420-2. 10.1016\/S2213-2600(20)30076-X","journal-title":"Lancet Respir Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang D","year":"2020","unstructured":"Wang D, Hu B, Hu C, et al.. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020, 323:1061-9. 10.1001\/jama.2020.1585","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang X","year":"2020","unstructured":"Yang X, Yu Y, Xu J, et al.. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020, 8:475-81. 10.1016\/S2213-2600(20)30079-5","journal-title":"Lancet Respir Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa113","article-title":"A 55-day-old female infant infected with 2019 novel coronavirus disease: presenting with pneumonia, liver injury, and heart damage","volume":"221","author":"Cui Y","year":"2020","unstructured":"Cui Y, Tian M, Huang D, et al.. A 55-day-old female infant infected with 2019 novel coronavirus disease: presenting with pneumonia, liver injury, and heart damage. J Infect Dis. 2020, 221:1775-81. 10.1093\/infdis\/jiaa113","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.055533-0","article-title":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment","volume":"94","author":"Lau SK","year":"2013","unstructured":"Lau SK, Lau CC, Chan KH, et al.. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol. 2013, 94:2679-90. 10.1099\/vir.0.055533-0","journal-title":"J Gen Virol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.01.025","article-title":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","volume":"104","author":"Mahallawi WH","year":"2018","unstructured":"Mahallawi WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018, 104:8-13. 10.1016\/j.cyto.2018.01.025","journal-title":"Cytokine"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar R","year":"2017","unstructured":"Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017, 39:529-39. 10.1007\/s00281-017-0629-x","journal-title":"Semin Immunopathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5669","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","author":"Ranieri VM","year":"2012","unstructured":"Ranieri VM, Rubenfeld GD, Thompson BT, et al.. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012, 307:2526-33. 10.1001\/jama.2012.5669","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00202","article-title":"On determining the age distribution of COVID-19 pandemic","volume":"8","author":"Cortis D","year":"2020","unstructured":"Cortis D. On determining the age distribution of COVID-19 pandemic. Front Public Health. 2020, 8:202. 10.3389\/fpubh.2020.00202","journal-title":"Front Public Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.06.033","article-title":"Hyperferritinemia in critically ill COVID-19 patients - is ferritin the product of inflammation or a pathogenic mediator?","volume":"509","author":"G\u00f3mez-Pastora J","year":"2020","unstructured":"G\u00f3mez-Pastora J, Weigand M, Kim J, et al.. Hyperferritinemia in critically ill COVID-19 patients - is ferritin the product of inflammation or a pathogenic mediator?. Clin Chim Acta. 2020, 509:249-51. 10.1016\/j.cca.2020.06.033","journal-title":"Clin Chim Acta"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu C","year":"2020","unstructured":"Wu C, Chen X, Cai Y, et al.. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020, 180:934-43. 10.1001\/jamainternmed.2020.0994","journal-title":"JAMA Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen N","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al.. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020, 395:507-13. 10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu Y","year":"2020","unstructured":"Liu Y, Yang Y, Zhang C, et al.. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020, 63:364-74. 10.1007\/s11427-020-1643-8","journal-title":"Sci China Life Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-06854-1","article-title":"CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city","volume":"30","author":"Zhang R","year":"2020","unstructured":"Zhang R, Ouyang H, Fu L, et al.. CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city. Eur Radiol. 2020, 30:4417-26. 10.1007\/s00330-020-06854-1","journal-title":"Eur Radiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103770","article-title":"Elevated lactate dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19","volume":"14","author":"Li C","year":"2020","unstructured":"Li C, Ye J, Chen Q, et al.. Elevated lactate dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging (Albany NY). 2020, 14:15670-81. 10.18632\/aging.103770","journal-title":"Aging (Albany NY)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.11.025","article-title":"Lactate dehydrogenase level as a COVID-19 severity marker","volume":"45","author":"Szarpak L","year":"2021","unstructured":"Szarpak L, Ruetzler K, Safiejko K, et al.. Lactate dehydrogenase level as a COVID-19 severity marker. Am J Emerg Med. 2021, 45:638-9. 10.1016\/j.ajem.2020.11.025","journal-title":"Am J Emerg Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803185","article-title":"C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations","volume":"381","author":"Butler CC","year":"2019","unstructured":"Butler CC, Gillespie D, White P, et al.. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. N Engl J Med. 2019, 381:111-20. 10.1056\/NEJMoa1803185","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-020-00362-2","article-title":"Plasma CRP level is positively associated with the severity of COVID-19","volume":"19","author":"Chen W","year":"2020","unstructured":"Chen W, Zheng KI, Liu S, Yan Z, Xu C, Qiao Z. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob. 2020, 19:18. 10.1186\/s12941-020-00362-2","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26031","article-title":"The value of clinical parameters in predicting the severity of COVID-19","volume":"92","author":"Shang W","year":"2020","unstructured":"Shang W, Dong J, Ren Y, Tian M, Li W, Hu J, Li Y. The value of clinical parameters in predicting the severity of COVID-19. J Med Virol. 2020, 92:2188-92. 10.1002\/jmv.26031","journal-title":"J Med Virol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/221062-association-of-inflammatory-markers-with-disease-progression-and-the-severity-of-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T03:47:35Z","timestamp":1708832855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/221062-association-of-inflammatory-markers-with-disease-progression-and-the-severity-of-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,24]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.54840","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,24]]}}}